AstraZeneca_NN
Annual_JJ
Report_NN
and_CC
84_CD
Form_NN
20-F_JJ
Information_NOMZ
2005_CD
CONSOLIDATED_NN
INCOME_NN
STATEMENT_NOMZ
FOR_PIN
THE_DT
YEAR_NN
ENDED_VBD
31_CD
DECEMBER_NN
2005 2004 2003_CD
Notes_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
Sales_NN
23,950_CD
21,426_CD
18,849_CD
Cost_NN
of_PIN
sales_NN
5,356_CD
5,193_CD
4,463_CD
Distribution_NOMZ
costs_NN
211 177 162_CD
Research_NN
and_PHC
development_NOMZ
3,379_CD
3,467_CD
3,012_CD
Selling_GER
,_,
general_JJ
and_PHC
administrative_JJ
costs_NN
8,695_CD
8,268_CD
7,393_CD
Other_JJ
operating_GER
income_NN
1_CD
193 226 188_CD
Operating_GER
profit_NN
1_CD
6,502_CD
4,547_CD
4,007_CD
Profit_NN
on_PIN
sale_NN
of_PIN
interest_NN
in_PIN
joint_JJ
venture_NN
2_CD
219_CD
Finance_NN
income_NN
3_CD
665 532 381_CD
Finance_NN
expense_NN
3_CD
500 454 311_CD
Profit_NN
before_IN
tax_NN
6,667_CD
4,844_CD
4,077_CD
Taxation_NOMZ
4_CD
1,943_CD
1,161_CD
1,033_CD
Profit_NN
for_PIN
the_DT
period_NN
4,724_CD
3,683_CD
3,044_CD
Attributable_JJ
to_TO
:_:
Equity_NOMZ
holders_NN
of_PIN
the_DT
Company_NN
4,706_CD
3,664_CD
3,022_CD
Minority_NOMZ
interests_NN
20_CD
18_CD
19_CD
22_CD
Basic_JJ
earnings_GER
per_PIN
$_$
0.25_CD
Ordinary_NN
Share_NN
5_CD
$_$
2.91_CD
$_$
2.18_CD
$_$
1.77_CD
Diluted_VBN
earnings_GER
per_PIN
$_$
0.25_CD
Ordinary_NN
Share_NN
5_CD
$_$
2.91_CD
$_$
2.18_CD
$_$
1.77_CD
Weighted_VBN
average_JJ
number_NN
of_PIN
Ordinary_NN
Shares_NN
in_PIN
issue_NN
millions_NN
5_CD
1,617_CD
1,673_CD
1,709_CD
Diluted_VBN
average_JJ
number_NN
of_PIN
Ordinary_NN
Shares_NN
in_PIN
issue_NN
millions_NN
5_CD
1,618_CD
1,675_CD
1,712_CD
Dividends_NN
declared_VBD [PUBV]
and_PHC
paid_VBD
in_PIN
the_DT
period_NN
21_CD
1,676_CD
1,408_CD
1,244_CD
All_QUAN
activities_NOMZ
were_VBD [BEMA]
in_PIN
respect_NN
of_PIN
continuing_VBG
operations_NOMZ
._.
CONSOLIDATED_JJ
STATEMENT_NOMZ
OF_PIN
RECOGNISED_NN
INCOME_NN
AND_PHC
EXPENSE_NN
FOR_PIN
THE_DT
YEAR_NN
ENDED_VBD
31_CD
DECEMBER_NN
2005 2004 2003_CD
Notes_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
Profit_NN
for_PIN
the_DT
period_NN
4,724_CD
3,683_CD
3,044_CD
Foreign_JJ
exchange_NN
adjustments_NOMZ
on_PIN
consolidation_NOMZ
18_CD
1,052_CD
744_CD
1,267_CD
Available_JJ
for_PIN
sale_NN
losses_NN
gains_VPRT
taken_VBN
to_PIN
equity_NOMZ
18_CD
10_CD
31_CD
1_CD
Actuarial_JJ
loss_NN
for_PIN
the_DT
period_NN
18 35 179 240_CD
Tax_NN
on_PIN
items_NN
taken_VBN [WZPAST]
directly_RB
to_PIN
reserves_NN
4_CD
,_,
18 25 416 139_CD
1,122_CD
1,012_CD
1,167_CD
Total_JJ
recognized_VBN [PRIV]
income_NN
and_PHC
expense_NN
for_PIN
the_DT
period_NN
3,602_CD
4,695_CD
4,211_CD
Attributable_JJ
to_TO
:_:
Equity_NOMZ
holders_NN
of_PIN
the_DT
Company_NN
3,595_CD
4,690_CD
4,186_CD
Minority_NOMZ
interests_NN
7_CD
525_CD
Tax_NN
on_PIN
items_NN
taken_VBN [WZPAST]
directly_RB
to_PIN
reserves_NN
in_PIN
2004_CD
includes_VPRT
a_DT
credit_NN
of_PIN
$_$
357m_CD
in_PIN
respect_NN
of_PIN
foreign_JJ
exchange_NN
losses_NN
in_PIN
2000_CD
Note_NN
4_CD
._.
$_$
m_JJ
means_NN
millions_NN
of_PIN
US_FPP1
dollars_NN
